| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |